Pharma Journalist -

Sun Pharmaceutical Industries Ltd. announced that one of its wholly owned subsidiaries has entered into exclusive licensing and supply agreements with Rockwell Medical Inc. (Rockwell),…
Read More...

NuMedii, Inc. announced a new partnership with a drug delivery company to develop new therapeutics for ulcerative colitis. The collaboration will bring together NuMedii's NM-001 asset…
Read More...

Artisan Bio, Inc., a stealth cell therapy engineering company, announced it has entered into a global research and collaboration agreement with Takeda Pharmaceutical Company Limited for…
Read More...

AstraZeneca and MSD Inc., Kenilworth, N.J., US announced that a supplemental New Drug Application for Lynparza (olaparib) in combination with bevacizumab has been accepted and granted…
Read More...

Galapagos NV and Fibrocor Therapeutics Inc. announced an expanded collaboration focused on novel targets in fibrosis, with Galapagos taking an equity stake in Fibrocor. Fibrocor is a…
Read More...

Clovis Oncology announced that the U.S. Food and Drug Administration (FDA) has accepted the company’s supplemental New Drug Application (sNDA) for Rubraca (rucaparib) and granted…
Read More...

Dermavant Sciences, a dermatology-focused subsidiary of Roivant Sciences, announced that it has entered into a collaboration and license agreement with Japan Tobacco Inc. (JT) for…
Read More...

ASC Therapeutics announced that it has entered into a long-term strategic manufacturing partnership with Vigene Biosciences, a Maryland-based Contract Develop and Manufacturing…
Read More...

ProBioGen AG and Lava Therapeutics B.V. announced the closing of a cell line development and manufacturing agreement for Lava’s novel bispecific antibody lead candidate. Founded in…
Read More...

My Green Lab announced a collaboration with AstraZeneca to implement a global-scale green labs program across their research sites as part of their commitment to sustainability,…
Read More...